Results 231 to 240 of about 26,046 (277)
Some of the next articles are maybe not open access.
Atrial Fibrillation: Antiarrhythmic Therapy
Current Problems in Cardiology, 2014Atrial fibrillation is the most common cardiac arrhythmia and is associated with significant morbidity, mortality, and economic cost. Although the benefit of anticoagulation has been well described, control of the underlying rhythm disturbance can be achieved in various ways. Numerous therapeutic options exist and continue to be developed; however, the
Mitchell A, Psotka, Byron K, Lee
openaire +2 more sources
Future Trends in Antiarrhythmic Therapy
Journal of Cardiovascular Pharmacology, 1991It is difficult to define what the trends will be in antiarrhythmic therapy in the coming years, particularly at a time when rhythmology has been somewhat destabilized by the unexpected results of large therapeutic trials on sudden death prevention. Schematically, drugs that do have established antiarrhythmic properties do not provide any benefit, and ...
openaire +2 more sources
Therapy with Investigational Antiarrhythmic Drugs
Medical Clinics of North America, 1984The investigational antiarrhythmic agents available for use in this country are predominantly class I drugs with local anesthetic membrane effects. These drugs are often used successfully to control arrhythmias refractory to treatment with the standard antiarrhythmic drugs.
R H, Mead, D C, Harrison
openaire +2 more sources
Current antiarrhythmic therapy overview
Cardiovascular Drugs and Therapy, 1990Cardiac arrhythmias are commonplace in the Western world and vary in their degree of seriousness from benign to life threatening. In general, arrhythmias may be managed in one of five ways: reassurance only, physical maneuvers, antiarrhythmic drugs, implantable electronic devices, and surgical or transvascular ablation.
openaire +2 more sources
Antiarrhythmic therapy in atrial fibrillation
Pharmacology & Therapeutics, 2010Currently available antiarrhythmic drugs for the management of AF are not sufficiently effective and are burdened with cardiac and extracardiac side effects that may offset their therapeutic benefits. Better knowledge about the mechanisms underlying generation and maintenance of AF may lead to the discovery of new targets for pharmacological ...
openaire +2 more sources
New Approaches to Antiarrhythmic Therapy
New England Journal of Medicine, 1981Concepts of antiarrhythmic therapy have undergone major changes in the past decade for a variety of reasons. First of all, electrophysiologic studies — ushered in by the observation1 that His-bundle activation could be recorded simply, safely, and reliably in human beings — have progressed from academic, research-oriented tools providing important data
openaire +2 more sources
Advances in Antiarrhythmic Drug Therapy
1992Publisher Summary Recently, electrophysiologic studies have suggested that the arrhythmias leading to sudden cardiac death may have a different mechanism and pathophysiology from those producing frequent premature ventricular contractions. This has led to the speculation that agents that affect the duration of the action potential and His-Purkinje ...
D C, Harrison, M B, Bottorff
openaire +2 more sources
Antiarrhythmic Therapy for Ventricular Arrhythmias
Journal of Cardiovascular Pharmacology, 1991Treatment of ventricular arrhythmias has received great attention during the past 20 years. However, results of recent trials with class I antiarrhythmic drugs in patients after myocardial infarction have raised many questions about the risk-benefit ratio of antiarrhythmic therapy, at least in asymptomatic subjects.
openaire +2 more sources
The American Journal of Nursing, 1980
J L, Stanford, J M, Felner, D, Arensberg
openaire +2 more sources
J L, Stanford, J M, Felner, D, Arensberg
openaire +2 more sources
Amiodarone in the antiarrhythmic therapy
Pharmacological Research Communications, 1983F, Furlanello +5 more
openaire +2 more sources